In the liver, these compounds can activate TLRs (TLR4), leading to hepatic inflammation, and in particular to the activation of liver resident macrophages (Kupffer cells), the first immune cells implicated in hepatic insulin resistance and in the development of steatohepatitis [17,45,46,47]. The gene discussed is TLR4; the disease is Insulin resistance.